A detailed history of Rockline Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Rockline Wealth Management, LLC holds 30,609 shares of ABBV stock, worth $5.6 Million. This represents 1.71% of its overall portfolio holdings.

Number of Shares
30,609
Previous 29,894 2.39%
Holding current value
$5.6 Million
Previous $5.13 Billion 17.89%
% of portfolio
1.71%
Previous 1.58%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$163.84 - $199.33 $117,145 - $142,520
715 Added 2.39%
30,609 $6.04 Billion
Q2 2024

Aug 01, 2024

BUY
$154.79 - $180.76 $172,281 - $201,185
1,113 Added 3.87%
29,894 $5.13 Billion
Q1 2024

May 01, 2024

BUY
$159.82 - $182.1 $76,234 - $86,861
477 Added 1.69%
28,781 $5.24 Billion
Q4 2023

Jan 12, 2024

BUY
$137.6 - $154.97 $3.89 Million - $4.39 Million
28,304 New
28,304 $4.39 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $324B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Rockline Wealth Management, LLC Portfolio

Follow Rockline Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockline Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rockline Wealth Management, LLC with notifications on news.